COVID-19 Update

The mountains will wait for us

An update about COVID-19 from Climb to Fight Cancer Manager Lisa Carlson

April 28, 2021

Lisa Carlson
Lisa Carlson, Climb Event Manager

Dear Climb community,

As you continue to make adjustments in response to the COVID-19 global pandemic, so too is the Climb to Fight Cancer. After postponing all of our 2020 climbs, we are offering domestic 2021 climbs to the adventurers postponed in 2020. Our guide services have made adjustments to provide for social distancing. Please email for more information. 

We need fearless science now more than ever. Hutch scientists are on the frontlines of this pandemic, balancing this urgent work with our core mission of advancing discoveries and curing cancer. I want to share an update with you about some of their exciting new research. Dr. Julie McElrath is leading the Seattle COVID-19 Cohort Study, which aims to decode the interaction between the virus and the immune system by studying people who are at high risk of exposure, as well as those who have already contracted the disease. Dr. Neelendu “Neel” Dey is piloting a “fail fast” study to explore whether it’s possible to target the microbiome to help patients recover more quickly or reduce the virus’s chance of spreading through fecal transmission. And Dr. Vivian Oehler is testing a broad panel of FDA-approved cancer drugs against COVID-19 to find treatments that could be effective in early-stage infection. Climb funding is critical to this important work.

I know this crisis has taken an enormous toll on all of us, but I’m inspired by the decisive actions of city and state officials, public health experts, Fred Hutch leaders, and our fellow citizens. These decisions are saving lives. 

Thank you again for all you do for Fred Hutch and Climb to Fight Cancer. Please continue to take good care of yourself and your loved ones.

Best wishes,

Lisa Carlson
Climb to Fight Cancer Manager

Helpful COVID-19 resources

Coronavirus microscopy image.

Fred Hutch coronavirus information hub

Information on Fred Hutch’s efforts to understand the pandemic and inform efforts to stop it.

People in active treatment, such as this patient being prepped for chemotherapy, or those who are immunocompromised due to past treatment, face a greater risk from COVID-19.

What cancer patients need to know

Advice for cancer patients, survivors, and caregivers on who’s most at risk for COVID-19 and what you can do to stay healthy.

Transmission electron micrograph of a SARS-CoV-2 virus particle, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland.

A short primer on coronavirus biology

A Hutch virologist explains the biology of viral pandemics and COVID-19.

health worker directs motorists at a COVID-19 drive-thru testing location in Stamford, Connecticut.

Recommended science papers

Amid the thousands of research publications on the novel coronavirus, here are the ones we recommend.